Authors: Gwen Clarke
, MD, FRCPC; Jacqueline Côté, MLT; and Debra Lane, MD, FRCPC
Publication date: October 2019
Primary target audiences: Medical laboratory technologists (MLTs) in a hospital laboratory, transfusion medicine physicians
- Anti-M is rarely clinically significant.
- Patients with anti-M should receive red blood cell units crossmatch compatible by IAT or equivalent using IgG antihuman globulin for transfusion.